首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >Biomarker discovery by comprehensive phenotyping for autoimmune diseases.
【24h】

Biomarker discovery by comprehensive phenotyping for autoimmune diseases.

机译:通过自身免疫疾病的综合表型发现生物标志物。

获取原文
获取原文并翻译 | 示例
           

摘要

There is a well-recognized but unmet need for biological markers to characterize disease type, status, progression, and response to therapy in autoimmune diseases. We are developing and applying an integrated bioanalytical platform and clinical research program to facilitate comprehensive differential phenotyping of patient samples and enable the discovery of biomarkers. Our measurement platform includes microvolume laser scanning cytometry for the quantification of hundreds of cellular parameters in whole blood and other samples, liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry for the quantification of proteins and low molecular weight biomolecules in serum and other fluids or tissues, and specific immunoassays for the quantification of trace proteins in serum. We describe the technologies and discuss initial applications to the analysis of subjects with rheumatoid arthritis (RA) and healthy controls.
机译:对于生物学标记物,以表征自身免疫性疾病的疾病类型,状态,进展和对治疗的反应,存在公认的但未得到满足的需求。我们正在开发和应用集成的生物分析平台和临床研究计划,以促进对患者样品进行全面的差异表型分析,并发现生物标志物。我们的测量平台包括用于定量全血和其他样品中数百种细胞参数的微体积激光扫描细胞仪,用于定量分析血清和其他液体中蛋白质或低分子量生物分子的液相色谱-质谱和气相色谱-质谱组织,以及用于定量血清中痕量蛋白质的特异性免疫测定。我们描述了这些技术,并讨论了在类风湿关节炎(RA)和健康对照受试者的分析中的初步应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号